Final Program in it's entirety - MyGirlsBlood

Recommendations

Info

Posters, Sunday and Monday Index of Poster Presenters cont’d INFECTIOUS COMPLICATIONS 16P05 Detection of HCV Mixed-Genotype Infection in the Hemophilic Population Aloisi N, Bastón M, Bracco M, Ruibal B, Pérez Bianco R, Baré P Academia Nacional de Medicina, Buenos Aires, Argentina 16P06 Presence of HCV Mixed-Genotype Infection; Association with HIV Coinfection Baré P1 , Aloisi N1 , Bastón M1 , Corti M2 , de Tezanos Pinto M1,2 , Pérez Bianco R1,2 1 2 Academia Nacional De Medicina, Fundación de la Hemofilia, Buenos Aires, Argentina 16P07 In Vitro System to Study Interactions between Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Bastón M, Baré P, Coraglia A, Bracco M, Ruibal B Academia Nacional de Medicina, Buenos Aires, Argentina 16P08 Beneficial Effect of Successful HCV Treatment in Patients with Inherited Bleeding Disorders: Non-Invasive Assessment of Fibrosis by Liver Stiffness Measurement Fransen van de Putte D1 , Fischer K1,2 , de Knegt R3 , Posthouwer D4 , van Erpecum K5 , Mauser-Bunschoten E1 1 2 Van Creveldkliniek, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3Department of Gastroenterology and Hepatology, Erasmus Medical Center Rotterdam, 4Department of Internal Medicine, University Medical Center Utrecht, 5Department of Gastroenterology and Hepatology, University Medical Center Utrecht, the Netherlands 16P09 The Burden of HCV Treatment in Patients with Inherited Bleeding Disorders Fransen van de Putte D1 , Fischer K1,2 , Posthouwer D3 , Mauser-Bunschoten E1 1 2 Van Creveldkliniek, University Medical Center Utrecht, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, 3Department of Internal Medicine, University Medical Center Utrecht, the Netherlands 16P10 High Frequencies of Exposure to the Novel Human Parvovirus, Parv4 in Hemophiliacs and Injecting Drug Users Detected by a Serological Assay for Parv4 Antibodies Gomperts E1 , Sharp C2 , Simmonds P2 , Donfield S3 , Lail A3 , Delwart E4 1 2 Childrens Hospital Los Angeles, CA, U.S.A., University of Edinburgh, Scotland, U.K., 3Rho Inc, Chapel Hill, NC, U.S.A. 4University of California San Francisco, CA, U.S.A. 62 16P11 Intracranial Bleeding in HIV Positive Hemophilia Patients on HAART Mauser-Bunschoten E, Fransen van de Putte D, Roosendaal G, Schutgens R, Fischer K Van Creveldkliniek, University Medical Center Utrecht, the Netherlands 16P12 Radiofrequency Ablation of Hepatocellular Carcinoma in 3 Patients with Hemophilia A Seita I1 , Amano K1 , Otaki M1 , Yotsumoto M1 , Imai Y2 , Fukutake K1 1 2 Department of Laboratory Medicine, and Department of Internal Medicine, Tokyo Medical University Hospital, Japan 16P13 FIBROSCAN ® : Non-Invasive Assessment of Chronic Hepatitis C Associated Liver Disease in Bleeding Disorders Kitson M1 , Roberts S1 , Kemp W1 , Iser D2 , Street A3 , Tran H3 1 2 Department of Gastroenterology, Infectious Diseases Unit, 3Ronald Sawers Haemophilia Centre, The Alfred Hospital, Victoria, Australia 16P14 Perioperative Treatment of Plasmatic and Thrombocytopenic Coagulation Disorders in Hemophilia B: Thrombocytopenia due to Chronic Hepatitis C Wolf H-H1 , Tcherkes A1 , Frühauf A1 , Oehme A2 , Zeh A3 1Clinic of Internal Medicine, Dept. of Oncology, Hematology and Hemostaseology, 2Institute of Medical Microbiology, and 3Clinic for Orthopedics, University Hospital, Halle, Germany 16P15 Retrospective Review of HIV in Hemophilia Population Alzahrani H, Shaheen M, Al-Rajhi A, Hussain F, AbuRiash M King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia LABORATORY SCIENCES 18P19 Could Global Hemostatic Methods (ETP and OHP) be Instrumental in the Individualization of Patients and Tailoring Treatment of Hemophilia A? Antovic J1 , Mikovic D2 , Holmström M3 , Soutari N1 , Elfvinge P4 , Antovic A4 1Coagulation, Department of Molecular Medicine and Surgery, Karolinska Institutet and Clinical Chemistry Karolinska University Hospital, Stockholm, Sweden, 2Hemostasis Department and Hemophilia Center, Blood Transfusion Institute, Belgrade, Serbia, 3Hematology Center Karolinska, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden, 4Department of Clinical Sciences, Danderyd Hospital, Division of Medicine, Karolinska Institutet, Stockholm, Sweden
Index of Poster Presenters cont’d 18P20 Antiphospholipid Antibodies in Patients with Inherited Hemophilia – A Laboratory Rather Than Clinical Problem Bulikova A1 , Smejkal P1,2 , Zavrelova J2 , Chlupova G21 , Matyskova M21 , Penka M1,2 1Medical Faculty Masaryk University Brno, Czech Republic, 2Department of Haematology, Faculty Hospital Brno, Czech Rebublic 18P21 Mixing Studies: Use of Specific Factor-Deficient Plasma Allows for Confirmation of a Single Factor Deficiency as the Cause of an Elevated APTT Moffat K1,2 , Chan A3 , Leonard B2 1Hamilton Regional Laboratory Medicine Program, Hamilton, ON, Canada, 2Department of Medicine, McMaster University, Hamilton, ON, Canada, 3Department of Pediatrics, McMaster University, Hamilton, ON, Canada 18P22 International Survey of Laboratory Tests Used in the Diagnosis and Evaluation of Hemophilia A Chitlur M and Gomez K Children’s Hospital of Michigan, Detroit Medical Center, Detroit, MI, U.S.A. on behalf of GEHEP 18P23 The Use of the New ReFacto AF Laboratory Standard (RLS AF) Allows Reliable Measurement of FVIII:C Levels in ReFacto AF Mock Plasma Samples by a One-Stage Clotting Assay Pouplard C1 , Aillaud M2 , Dreyfus M3 , Sobas F4 , Ternisien C5 , Dubanchet A6 , Caron C7 1 2 Dept hematology-hemostasis, CHU Tours, France, Dept hematology-hemostasis, CHU Marseille, France, 3Dept hematology-hemostasis, Kremlin Bicêtre AP, Paris, France, 4 5 Dept hematology-hemostasis, CHU Lyon, France, Dept hematology-hemostasis, CHU Nantes, France, 6Dept hematology-hemostasis, Pfizer, Paris La Défense, France, 7University Hospital, Lille, France 18P24 Recent Initiatives and Ongoing Activities in External Quality Assurance for Bleeding Disorders Favaloro E1 , Bonar R2 , Sioufi J2 , Marsden K3 1 2 ICPMR, Westmead Hospital, Westmead, Australia, RCPA Hematology QAP, Northmead, Australia, 3Pathology, Royal Hobart Hospital, Hobart, Australia 18P25 Anti-FVIII Inhibitor Levels Measured by One-Stage Assay or Chromogenic Assay Show Significant Discrepancies that Might Lead to Inappropriate Clinical Decisions Gilles J, Grailly S, Peerlinck K, Jacquemin M, Saint-Remy J CMVB, University of Leuven, Leuven, Belgium 18P26 Contribution of Natural Anticoagulant Factors in Modulating the Phenotypic Heterogeneity of Chinese Hemophiliac Patients Hua B, Zhao Y, Luo T, Fan L, Li K Peking Union Medical College Hospital, Beijing, China 18P27 Effect of Measuring FVIII Chromogenically in the Bethesda Assay for FVIII Inhibitors Kershaw G1 , Jayakodi D2 , Dunkley S1 1 2 Royal Prince Alfred Hospital, Sydney, Australia, University of Peradeniya, Sri Lanka 18P28 Why Do FVIII Assay Results Vary So Much Between Different Centres? Data On FVIII:C Assay Design as Used by U.K. NEQAS BC Participants Kitchen S, Jennings I, Kitchen D, Woods T, Walker I U.K. NEQAS Blood Coagulation, Sheffield, U.K. 18P29 Thrombin Generation Test (TGT): Could It Be a Good Tool for the Care of Severe Hemophilia A with Inhibitors? Lê P, Filippin L, Demulder A Hôpital Universitaire Reine Fabiola Bruxelles, Belgium 18P30 New Immunoassay for Hepatitis C Virus Antibody Detection with More Sensitivity Luna-Záizar H1 , Romero-Flores M, Contreras A 1 2 CUCEI, University of Guadalajara, Mexico, Colegio de QFB al servicio de Jalisco, Mexico, 3Coordinación de Investigación en Salud IMSS-Jalisco, Mexico 18P31 Expanding Care of Bleeding Disorders in Brazil: Improvement of Hemostasis Diagnostic Laboratory Montalvão S1 , Sternick G2 , Rezende S3 1Unidade de Hemofilia do Hemocentro da UNICAMP, 2Ministério da Saúde- Coordenação Geral de Sangue e Hemoderivados-CGSH/DAE/SAS, 3Universidade Federal De Minas Gerais 18P32 Epitope Mapping of Factor VIII Inhibitor Antibodies in Thai Hemophilia Patients with Inhibitors Pongtanakul B, Narkbunnam N, Mahasandana C Division of Hematology and Oncology, and Department of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok, Thailand 63 Posters, Sunday and Monday
Page 1 and 2: Hemophilia Saturday, July 10 - Wedn
Page 3 and 4: Pre-Congress Sessions cont’d 10:3
Page 5 and 6: Pre-Congress Sessions cont’d 15:0
Page 7 and 8: Congress Sessions cont’d S1.6 - M
Page 9 and 10: Congress Sessions cont’d S2.5 - M
Page 11 and 12: Congress Sessions cont’d n Long T
Page 13 and 14: Congress Sessions cont’d M2.4 - M
Page 15 and 16: Congress Sessions cont’d Tuesday,
Page 17 and 18: Congress Sessions cont’d 14:15 -
Page 19 and 20: Congress Sessions cont’d T3.4 - M
Page 21 and 22: Congress Sessions cont’d n Inhibi
Page 23 and 24: Congress Sessions cont’d W2.4 - L
Page 25 and 26: Index of Speakers cont’d Halimeh,
Page 27 and 28: Index of Poster Presenters Sunday a
Page 29 and 30: Index of Poster Presenters cont’d
Page 47: Index of Poster Presenters cont’d

Final Program in it's entirety - MyGirlsBlood

Create successful ePaper yourself

Delete template?

Save as template?